Clinical Trials Browser

Phase 2 × Acetaminophen × 1 year × Clear all

NCT06788912 2026-06-01

MK-3475-01E

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT04165096 2026-05-13

MK-3475-01C

Phase 2 Completed

128 enrolled 14 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT06009926 2026-05-13

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Phase 2 Active not recruiting

Other neoplasmOther solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06043323 2026-05-06

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular

NCT04268498 2026-03-24

ADVANCE

Phase 2 Active not recruiting

Multiple Myeloma

NCT02439034 2026-03-16

KETOCOL

Phase 2 Completed

GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT05896228 2026-03-11

Iber-KDd

Phase 2 Recruiting

Multiple Myeloma

NCT03913559 2026-02-12

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Phase 2 Completed

34 enrolled 22 charts

Sarcoma, Alveolar Soft Part

NCT05704049 2025-12-29

IZALCO

Phase 2 Active not recruiting

Multiple Myeloma

NCT05842044 2025-09-05

No-PAIN

Phase 2 Recruiting

Kidney Neoplasms

NCT00712712 2025-08-29

MEDOR

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain